DCGI approves Bharat Biotech Nasal Vaccine
New Delhi, 28/1: The Drug Controller General of India (DCGI) has approved the trial of Bharat Biotech’s Nasal Vaccine. This vaccine will be used as a booster dose. At present, its trial will be done on 900 people. This will be the trial of the third dose of this vaccine. The company had sent the…
